NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 205,200 shares, a decline of 17.7% from the December 31st total of 249,200 shares. Approximately 2.3% of the shares of the company are short sold. Based […]
Stock analysts at Alliance Global Partners began coverage on shares of NeuroSense Therapeutics (NASDAQ:NRSN – Get Free Report) in a report issued on Monday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. NeuroSense Therapeutics Trading Up 0.7 % NeuroSense Therapeutics stock opened at $1.39 on Monday. The stock has a 50-day moving […]
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Free Report) saw a significant decrease in short interest in June. As of June 15th, there was short interest totalling 78,300 shares, a decrease of 38.8% from the May 31st total of 127,900 shares. Based on an average trading volume of 74,700 shares, the short-interest ratio is presently 1.0 days. […]
NeuroSense Therapeutics (NASDAQ:NRSN – Get Rating) is one of 993 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare NeuroSense Therapeutics to similar businesses based on the strength of its valuation, analyst recommendations, institutional ownership, profitability, earnings, risk and dividends. Analyst Recommendations This is a summary […]
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Rating)’s share price was up 6.3% during trading on Monday . The company traded as high as $2.05 and last traded at $2.02. Approximately 89,983 shares traded hands during trading, a decline of 92% from the average daily volume of 1,173,931 shares. The stock had previously closed at $1.90. […]